Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.46
0.00 (0.00%)
Aug 10, 2026, 10:43 AM EDT - Market open

Sanofi Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
48,91946,71644,28641,61840,56139,175
Revenue Growth
6.96%5.49%6.41%2.61%3.54%4.83%
Gross Profit
35,59633,66731,08128,99028,67926,920
Operating Income
5,7536,3447,2526,96010,1628,126
Net Income
3,9587,8135,5605,4008,3716,223
Earnings Per Share
1.643.192.212.153.332.48
EPS Growth
-55.87%43.79%3.02%-35.44%34.54%-49.28%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dupixent
17,72615,71413,07210,7158,2935,249
Pharma
38,00535,69032,783---
Total Vaccine
7,8387,9368,2987,4747,2296,323
Revenue (Total)
48,91946,71644,28641,61840,56139,175

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6,3507,6577,4418,71012,73610,098
Total Debt
23,57620,32917,90618,42221,21222,414
Net Cash (Debt)
-17,226-12,672-10,465-9,712-8,476-12,316
Net Cash Growth
------
Net Cash Per Share
-7.13-5.17-4.17-3.87-3.37-4.90

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
8,87810,7509,08110,25810,52610,522
Capital Expenditures
-3,414-3,538-3,195-2,906-2,103-2,043
Free Cash Flow
5,4647,2125,8867,3528,4238,479
Free Cash Flow Growth
-34.98%22.53%-19.94%-12.72%-0.66%182.07%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
72.77%72.07%70.18%69.66%70.71%68.72%
Operating Margin
11.76%13.58%16.38%16.72%25.05%20.74%
Pretax Margin
11.11%13.22%15.12%15.02%24.50%19.91%
Profit Margin
8.65%10.99%12.41%12.58%19.79%15.93%
FCF Margin
11.17%15.44%13.29%17.67%20.77%21.64%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.7654.1203.9203.7603.5603.330
Dividend Per Share Growth
10.40%5.10%4.25%5.62%6.91%4.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.0712.9720.9320.9213.5617.80
P/FCF Ratio
8.9913.9719.7415.3113.4313.02
PS Ratio
1.872.162.622.712.792.82